机译:DNA修复多态性影响儿童急性淋巴细胞白血病治疗后第二肿瘤的风险
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000, Ljubljana, Slovenia;
Department of Hematology and Oncology, University Children’s Hospital, University Medical Centre, Bohoričeva ulica 20, 1000, Ljubljana, Slovenia;
University Children’s Hospital, Centre for Medical Genetics, University Medical Centre, Vrazov trg 1, 1000, Ljubljana, Slovenia;
Department of Hematology and Oncology, University Children’s Hospital, University Medical Centre, Bohoričeva ulica 20, 1000, Ljubljana, Slovenia;
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000, Ljubljana, Slovenia;
Childhood acute lymphoblastic leukemia; DNA repair; Polymorphisms; Second neoplasm;
机译:DNA修复多态性影响儿童急性淋巴细胞白血病治疗后第二肿瘤的风险
机译:单独使用DNA修复XRCC1 Arg399Gln多态性,并与CYP2E1多态性结合,显着增加了儿童急性淋巴细胞白血病发生的风险。
机译:DNA修复基因多态性及其与儿童急性淋巴细胞白血病幸存者的DNA损伤,DNA修复和总抗氧化能力的关系
机译:急性淋巴细胞白血病的结果:硫氨酸甲基转移酶生物态的影响
机译:儿童急性淋巴细胞白血病清髓性造血干细胞移植后生存和治疗相关死亡率的回顾性分析。
机译:DNA修复基因XRCC1基因多态性与儿童急性淋巴细胞白血病易感性的荟萃分析
机译:X射线修复交叉互补组1(XRCC1)遗传多态性与儿童急性淋巴细胞白血病的风险:荟萃分析